As of 2025-05-29, the Gross Margin of Samsung Pharm Co Ltd (001360.KS) is 44.6%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 44.6% |
2023-12-31 | 44.2% |
2022-12-31 | 47.5% |
2021-12-31 | 16.9% |
2020-12-31 | 21.7% |
2019-12-31 | 21.1% |
2018-12-31 | 18.5% |
2017-12-31 | 12.1% |
2016-12-31 | 18.6% |
2015-12-31 | 26.7% |